AI‐based staging, causal hypothesis and progression of subjects at risk of Alzheimer's disease: a multicenter study

Abstract

Background: In 2024, eleven European scientific societies/organizations and one patient advocacy association have defined a patient‐centered biomarker‐based diagnostic workflow for memory clinics evaluating neurocognitive disorders.